Boston Scientific invests $1.5B in MiRus for 34% stake

Boston Scientific invested $1.5 billion for an approximately 34% equity stake in MiRus LLC, a developer of biomaterials and implants for cardiovascular and orthopedic diseases. Boston Scientific also received an exclusive option to acquire MiRus' TAVR system.

“The occurrence and recognition of aortic stenosis is growing rapidly and our investment in MiRus continues our pursuit to bring a differentiated TAVR system into our portfolio that we anticipate may improve outcomes for patients living with this life-threatening disease.”mirusmed.com

• 1 source
• mirusmed.comBoston Scientific announces strategic investment in MiRus LLC - MiRusPriya YadavMay 18, 2026

Summarized from public sources; check the original articles before acting on it.